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(67 9%=) SSS patients and 10 of 13 (76,9%) AVB patients As the s~do ~.ff ,~cts, 
palpitation, dry mouth, headache and othm adverse symptoms were sOOn on 
9 (t 8%) patients, but all these symptom.~ WOrD chmcally mdd and tolerable 
Conctu~on S=gmhcant improvement of bmdyarrhylhmlas was obtamed 
By oral adm~n~sfmbon f AF-DX cndtcabng thai thus now ngonf can be used 
for loop-It,,( control of mdd to moderalo bradyanhylhmla and also as a 
lompor~try bndgo onltl pormaneflt pacemaker implantation 
• A!dost~mne Causes Oaro~optot Dysfunction In 
. . . .  Man 
K M Yea. AD Slruthers t"Aep~lrtme..nt ot Chmcat Pt~rmaCotog¥ Ninevv~lf~ 
Ho~p~tat, O~ndee UK 
~L~cAg~aun~ Oamletl0x dysfunction is a key process leading to ventr~cu~a~ 
arfllylnmras a~! mo,rtalt~ In chrooK: heart failure (CHF) Aldosterone r~as 
been Shown to impair the bafo~eceptof ~'esponso in animal models Th~s 
study tS deslgne~ to test the bypotbesis that aldostemne directly atlenuates 
the ba'~o[ette~ n k,~vo in man 
Methods: Fourteen healthy mate volunt¢....e~s [mean age (SD) 25 (9)} m- 
cei~e~ iv d-aldostefone (t2 pmot.~,gYmln) and placebo in a double blind 
cros.~-~ve! fashion, comtu~ed w~tt't fr~emental closes of Iv phenytephnne 
(PEt and sodium naropruss~e (SNt 
Ftesutts Baromttex se,nsltwlty was s~gnthcantly blunted in the aldoslefone 
grOup [B 4 (gSer=Ct 75-92) vs tO 1 (g5%Cl 9 3-11 0) msec/mmHg p 
0 01) Reflex heart rate (HR) response to PE were 0repaired white BP re- 
sl~-x)nses were unalternd liable t | Al~k3sterone had no slgndEant efled on 
the in~en~h/nam~c response to SN 
PE Pt ACEBO ALDO 
O¢~:-e %i0P Irnt'nH~]) ~HR (l~t rn~r~i %s~P ~HR 
06 '~25~,1 1691 83~61 1061 135t90 179)  35(1356)"  
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Va~es ~re fLfe~n i95 % Ch "P 005 r p O O f corr~are~3 v.~rt~ 31.~.'e~.~ 
Conctus~n Th~s ts the first study to show that aldosterone rmpalrs Barore- 
ceptol funchon in man H~gh ak:tosterone levels causing Baroreftex o'yslunc- 
t:un may contribute to armvmmogenes~s and sudden carmac death ~n conch- 
boos such as CHF 
1225-39 i The Significance of Plasma Renin Levels in 
Patients With Dilated Cardiomyopathy on 
Ti=orapeutic Doses of ACE Inh ib i tor  
N V Nraman. M K¢= Ip J Hoc)per D G Gd;~on Ro~al Bro~np~o,.1 Hos~o~al 
Lot!~(~n UK 
TO StUdy interrelations between h.aemod~nam~cs and ren~n-anglotensm sys- 
tem we measured BNP. ANP. reran. ACE and aldosterone taK~o) ~n p~asma 
LV long (LA) and short iSA) a~es by M-mode ochocarOogfaphy ~n 35 pa- 
tients w~th ddated cardlomyepathV (DCM) raking therapeubc doses el ACE 
mhtb~tor 
In group I (15 pts) ptasm~ renm '.';as 100 pg:ml (43 5 : 23 If. and 
greatermgroupllt24746 : 25794} LVESD(50 : 12cmv65 ~ 1 5 p 
0001)andEDD(62 : 10v74 : 14. p.  0002).ptasmaaldoi2846 : 
221 2 pmoH v 674 9 : 463 0. p 0 001 ) were all greater m II gr whde ACE 
level(353 : 374=uAv 15.0 ~ 19.3. p . 003).LVEFI202 : 106v  137 
47  p.  002) and peak shortemng rates of LA (3 4 : 1Bcm,'sv23 = 1 1.p 
- 0 04) were less ANP and BNP dud not differ beh*;een the groups (11 0 : 
7.4pmol ' lv189 : 231 .p  009and193 : 184v2°,.3 : 207 p 024)  
but m It gr. but not I gr. were closely correlated with ACE level (r = 0 70 and 
0.86) By contrast. ,n I gr. but not I1 gr. Correlation was present beh';een SA 
and LA peak shortening rates, r = 058 and lengthening rates, r = 0 67 
Thus nn pabonts wdh DCM on therapeutic doses of ACE unh=b[tor, values 
of plasma renin . 100 pg/m!, but not ANP or BNP. are markers of larger cavrty 
size. reduced shortenmg rates and lower election fraction. Consustent loss at 
normal coordination beh'~een SA and LA funchon in patients wdh h~gh renm 
suggests advanced remodethng 
~ Locat Increases Endothelin Hyperinsulinemia 
' Activity in the Human Forearm Ci rcu lat ion 
C. Carddlo, S.S. Na, ibl. C.M. Kilcoyne. MJ. Ouch. J A. Panza. NHLBI. 
Bethesda. MD. USA 
To investigate a potential mechanism linking hypennsulinemia with hyper- 
tension and atherosclerosis, we examined whether insulin modulates the 
v,'ISO~CTlvO offoct~ of endothehn (ET-1 L a va~r~coPMnclor an,.1 m0to~e~tc pep 
tide TO this purpose, we moasurecl the forearm bided flow (FBF srram-gaz~e 
plethysmogr~phy) responses to l~T. I receptor blockad~ dunng mtus~on of e,. 
thor sahno or unsuhn m 8 healthy subjects on 2 ~eparate day~ Dunng ~a1~r,.~ 
intraarierla! mtusiOn of an ET^-receptor blocker (BQ.123, 100 nmol;min for 
60 rain), alone and in combination with aa ETh-rI~..~ptef antagoe sl (BO7Bb 
50 nmol!mm for fudhor 60 mint d~0 net signdicantiy change FBF (2 g ~ 02 
{mo,~n r SEMI mLJmirvdL briar0.2'9 ~ 0.2 mUm~wdL alter IBQ.123 alone 
28 ~ 0:2 mlJmIR'dL ~lttor the combination of BQ.123 and BQ.788; P = 0 20) 
lnsutin admzmstr~tlon (0.1 mU/kgYmln for 2 hr) resulted m a mafkec! ,~  ~e 
*n local msutun concentration (from 3 ~ 1 to 295 : 69 t,U/mL; P = CJ 004 L b~t 
did not readily FBF 123 : 0 t  ml.Jms~'dL before and 2 2. ,  ~1 migrate'alL 
after 2 hf el msu!ln infusion; P =- 0.,~8). During hyperlnsuht~mta, ET*t re, 
copter antagonism CauSed a v~oddat0r effect, wilh a FBF increase of 2,5 : 
9% after 60 mm of selective ET^ b|ockEK:~ and Of 52 -* 7%. after 60 mln at 
combined ETa, and ETa antagonmm (P - 0.001 ) These hndmgs suggest that 
msuhn shmufates vascular production of ET.1, which may c0mnbute to me 
hypertenswe and atherogemc effects el hypeensuhnem*a The obsen~at~on 
that msuhn does not moddy vascular tone in the absence ot ET.1 receplor 
blockade ~ compatible wdh the oonourrent act~vabon o! vasod~latm ech- 
amsm5 thai phy~lotog~catly balance the vasoconstnctor effecl of mcreased 
ET*t 
J E f fects  o f  Dobutsmlne  Admtn l i t ra t ion  on  Timing 1225-53  
of Atrial Contra¢lion and Syaloli¢ PeHmmance of 
the Left Atrium in Normal Subjects and In Patients 
With Heart  Failure 
J Demelhs, C Stefanadis, K Toutouzas, E Tslamls, S Vanna C Putsavos 
P Toutouzas Department at Card~elogy. Um~ersrty ot Athens, Amens, 
Greece 
Background Mc~han~cal effects el atr~ventncutaf mterachon play an ~m- 
poda~ role in ventno, J[tar hthng dunng tachycafdla. As heart rata iRcreases 
atnal contracbo~ occur5 earlier in diastole and thereby influence ventncular 
¢ilhng throughout a rate-Iimated la~'lahc peflod The ,nfluence at dobutamme 
~nfuslon oe the loll atnal (LA) sys~le was studled in 11 non'naI SubleC15 and 
~n 7 palmers w~tn hea,1 fadum who were atnally paced at a heart rate equal 
re that achieved by dobutamme infusion. 
Met'nods. We have 3pphed real-tume two-atmens~3naI ech~ardtographlc 
=magmg wTth ~utomat~c boundary detection (HP SanDs 2500) for the esti- 
mation of LA area changes To obtain the LA pressure= a catheter41p m~cro- 
manometer was t~roduced retrogradeh/Into the LA using a steerable cardiac 
catheter developed =n our mststutmn (Cordls Europa 5RE-699) The rat~o at 
,nstantaneous LA pressure to LA area was catculated throughout he carOac 
cycle and usecl as a measure of LA elastance JEll)) From the d=gdlzed ata 
PR electrocardiographic inte~al and Lhe lime Interval tram the onset of P 
~ave to the maximum E~ (At) were also measured Data were collected 
i3~th b~fore and attar dobutamme infusiot~ at a rate 5-20 ~=~,l,~g.~mln 
Resutf~ After dobut~m~ne intuslan ma~lmulT= E ,  if~-;oa"ed |101r~l 143 
0 19 to 2 56 : 0 ~G mmHg;~;m: in nurmats Ip 000t  v5 pacing) and from 
0 73 : 0 09 to 0 89 ~ 0 10 mmHg~cn~ n heart failure (P 0 05 vs pacmg) 
Th~s ~r~cre,'L~e h we~'er was larger m nomrals, p - 0 01 In all subiects the 
PR mferval was significantly reduced (by 170 t 2 7%1 afler dobutan'~ne 
compared with areal paong (140 3 ~ 162 vs 1695 ; 22 7 reset, p.  0001) 
Moreover ~,! was s~gmhcanlfy reduced (by 22 1 : 1 2%) attar dobutamme 
compared w~th atnal pacmg (1255 ~ 195 vs 16t 2 "- 258 msec. p - 000t) 
A p~ltwe correlation between per cent changes of PR mrerval and per cent 
changes of ~t 0nterval was found (.~.t = 033 PR 0 16 r = 0 76) 
Canc/us~ons. An mcreased motroplc state m the same level at heart 
rate resulted in an mcreaso of LA systolic elastanco However. response to 
inotroplc stimulation was reduced on fading LA myocardtum FurthermOre, 
ample time =s Iolt for the atrial kick' to boost ventrtcular filhng in all sub. 
loots dunng the tmrly short per~od that ~s defined by the PR referral after 
dabutamlne infusron 
i 1225-54  i Long- term Character izat ion of  the  
. . . . . .  Amiodarone-Wadarin Drug In teract ion  
C A SanoskL J L Bauman The Unwers~tv of Ilhno~s at Chicago Chicago. 
IL USA 
Background The mterachon bekveen amnadaru~e (A) and wadann (WI has 
only been described on small numt}ers el pa!,~=ms IL)I=,) bemg followed for - B 
weeks. The purpose of th~s tudy was to characte,.ze th~s drug mteract~on 
over a longer brae penod in a larger cohort ot pt~, 
Methods. We followed 35 pts recennng both A and W for . 1 year: 22 were 
male and 13 female, aged 60 ~ 14 years. The dosage of W was adlusted on 
a monthly basis to achieve an INR of 2-3. 
tPPsults: The magn0tude of the mteractten peaked at 7 weeks whtoh 
resulted in a 42°° mean max=mum reduction in the W dose The W dose 
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inversely correlNed with the dose o! A (r ~ = 0.US. p -~ 0.01 ), At baseline, prior 
to initiation of A, the W ~u~,e was 4,8 ~: 2,7 rag/day. It is predicted that pts 
receiving an A m~tntonanco dose of 400 mg/day require s 35% reduction In 
the dose of W: 30% reduction for 300 rag/day; 26% reduction for 200 mg/dey: 
and 21% reduction for 100 rag/day (Fig,) Minor bleeding episodes occurred 
In 5 (14%) of the pts, 
), - .0,00~17= + 3,996 
r ~ - O,gtl 
| l l ,  ~ . . . . . . .  + l . . . . . . . . . . . . . . . . . .  ++ , -+ 
4PA+ 1~1 |r~ +m) 
Amle ld~P~ne I )nw (mlZ~f )  
G"Pn~llmfPns: The m~gnltude of tl~a A-W interaction is highly dependent 
upon the m~inlananie dose o! A, Those findings can be used to dnveicp W 
dosing guidollnas in pts concurrently recalvlng long.term A therapy, 
~ Elootrophyl lologlesl  EtteQt of Acute 
Administration of EIItradlol t7~ In MQnopau|l+ll 
Women 
G,M,C, R0s~no, M, RIIIo, F, Leonardo, C, Pappnce, R, Patnzi, 1", Russo, 
I+ Shetbsn, S,L, Chta~hlA, O.f~pt, of Cardto~y, I,'~ttfuto ScienttfK:o H San 
Ff,qft'mto, Mtlano,Rem~, linty 
Ovarian hormones have L'~en shown to axed several effects upon the cardlo, 
vascular System, In v~tre studios have suggested that those substances may 
affect the oloctrophysiolog~oal prel~diea of isolated cardmc myocytes, The 
aim of the present study was to lnvoMtgato whether the acute administration 
of estradlol fTl! has any olectrephyslologtcal effect on the human head m 
16 menopausal women undergoing electmphysiologtcal study (EPS), Pts 
underwent 2 EPS, at bssohno and 20 minutes attar administration el either 
estredtol 1711 (E2, 1 mg subllnguelly; Group A: 8 pts) or placebo (P, sublin. 
Gually; Group B: 8 pts), alood samples for the evaluation el seam estrediol 
17p were obtained tam the comnanJ sinus before the administration el the 
study drag end at the end el the study protocol. E2 caused a significant 
mcrease el Right Interatnal Conducbon T~me (22,25 :t 7,64 msec vs 25.7 
7,41 msoc, p ,  0,01) Atno-ventncular Node Conduction Time (70,75 * 10.22 
msec vs 84.37 ~ 17 msec, p - 0,05) and el Effective Retrecton/Period at 
Right Atnum (198,75 , 1552 msec vs 208.75 ~ f2,46 msoc, p • 0.05), No 
s~gnttlcant differences tn any measured parameter wore obtained alter P E2 
plasma levels stgnltlcsntly (ncresed in group A patients (8,57 ~ 6,62 pg/I vs 
1S7,5 ~ 87 pg/I; p ,  0,01) while no differences were obtained In group B. In 
conclusion, these data show that ovarian hormones have eloctrophysiotog- 
+cal prope~os which may be o! (mportan~ duting hormone dopnvation or 
pregnancy. 
Exemlse Adaptation In Heart Failure 
Wednesday, Apfll 1, 1998, 3:00 p,rn,-5:00 p,m, 
Georgia World Congress Center, West Exhibit Hall Level 
Presentation Hour: 4:00 p,m,-5:00 p,m. 
~ Impact of a Home-based Exercise Program on 
Quality el Life In Patients With Class II-Ill Chronic 
Heart Failure 
R K. Oka, T. De Marco, K. Bolen, E Botvinick, M, Dae, S+ Woodley, 
W L HaskeU, K. Chatterjee. Univ of California, San Francisco, Kaiser 
Permanents.Santa Teresa. & Stanford Univerai~ USA 
While the physiological benefits of exorcise have been described in patients 
with chronic heart failure (HF), little is understood about the potential impact 
of various exercise regimens on Quality of I+fe (QOL). The purpose el this 
randomized trial was to evaluate the effects at a comprehensive home-based 
exorcise program on QOL (n 24 men and women ages 30-76 years (mean = 
56,4 years) with stable, chronic Class I1-111 HF and LV dyslunction. Following 
baseline evaluations that consisted of psychosocial questionnaires and phys- 
ical pedom~ance l sto, all subiacts were randomizad to a 12.week combined 
walking and resistance exercise or usual care (UC) group, The exercise 
program consisted of 3 days of moderate intensity walking altomating with 2 
days of resistance exomlsss pedotmed et home. Subjects were retested at 
12 weeks, QOL was assessed using the interviewer administered Chronic HF 
Questionnaire (CHQ) that consists of 4 aubscales: dyspnea (5 Items), fatigue 
(4 items), emotional function (7 items), end mastery (4 items), Pdor clinical 
experience showed that an increment of 0,5 units per item In each eubscele 
demonstrated a slgntflaant change in subjeCts day-to-day lives, ExemtN ad- 
herence was monitored via self.repeded exercise logs and conflonod ~a a 
podable HR end activity monller, Adherence was excellent (90%), At poll~lt 
exercisers demonstrated Improvement In 3 dimensions: fatigue (p ,,, 0,02), 
emotional function (p., 0,01), and mastery (p ,+ 0,04) compared to tl~ UG 
group, While changes in dyspnea dld not roach statistical slgnlfl~nce (p 
0,08), clinically significant change tn exemtsem (25,7) compared to UC (19,8) 
was domonstmtnd, We cenclutk| that 8 1R.weok home.b,~|ed walking and 
melstanco oxerelse program was elfacflvo In ImptovlnG m/mpteml e fatigue 
and dyspnea, emotional lunatics, and mastery, impedant components that 
influence QOL In patients with chronic HF •nd LV dysfunction, 
~ I)ewlopmont of Shuttle Walk !I~M In PallenM a 
With Ht t f t  Failure and Its Compnd lon  With 
8Ix.Minute Walk Tat  
F J, Morales, A, Madlnoz, M, M~entlez, A, Agetrado, F~ Odoga, 
T, Montemayor, J Bulges, Vlrgen clel Roc~ UnNef~tafy Hospital, Sardis, 
S~in 
f)ackGfound: Measurement el peak oxygen conaumptKm (peak VO2) is a 
complex procedure, and expensive equipment is needed, We analyzed the 
relationship o! more simple and available exe¢ise tests, the shuttle walk test 
(SWT) end the e~-m~nute walk test (6.MT), with peak VO2 and befcom of 
predicted peak VO2 (%PVO2) in patients with congestive head failure (CHF). 
Methods: We studied 40 psi!eats (8 women), aged 52 + 10 years w=lh 
dilated nardiomyol~thy and EF ~0.40 (mean 0,23 + 0,10), who were m 
NYHA tunctieast clams g-IV (mean 2.8 .,1: 0.0), Each patient performed a 
cardiopulmonary osem+se testing (CPET) with peak VO2 delelminati(~, so 
as two SWT and two 6,MT within 2 weeks el 1heir peak V02 measurentent, 
Tho SWT iaa progressive nd symptom-limited test, which requires patients 
to walk tip end down e lO, m course, The ~-,peod i~ controlled by a series 
of beeps played on e fags cassette, Each minute the speed el walkmg is 
increased by 0.17 nVs, 
Results: We teund e close correlation between distance walked in SWT 
and peak VO2 (r =, 0.83, p -~ 0,001), and a moderato correlation between 
distance in 6-MT end peak VO2 (r = 0.68, p -~ 0.001). There ware siged. 
icanlly higher values in maximum heart rate, systolic blood pressure, and 
rating ot perceived dyspnea at peak exercise in SWT compsmd ~th such 
parameters in 6.MT. The first 17 patients developed 3 SWT and 3 6-MT 
0nstood oi 2 ot each), and both walk tests showed to be reproducible alter 
iust one practice walk. Stapwise multivariate regression analysis, including 
clinical, exercise testing, radionuclide-angiographic, pulmoean/lunction and 
rest hemodynamic data, showed that distance walked in SWT was the only 
independent predictor el peak VO2 (p -. 0,0001), and the strangest i:ml3d~o~ 
of %PVO2 (p < 0,001), with only age providing additional intelmation to 
%PVO2 (p = 0,02), A cut-off value el 3S0 m in SWT reached the highest 
diagnostic accuracy for predicting a peak VO2 < 14 ml/kgtmin, a threshold at 
which heart transplant is considered. 
Conclusions: The SWT is an adequate and simple method to assess 
functional capacity in CHF patients. It is a strong and independent predictor 
of peak VO2 and %PVO2. The SWT might be useful in the screening of those 
patients who should be referred for further transplant evaluation, specially in 
the ambulates/setting where CPET may not be available. 
~ Randomized Trial of  Exercise Controlled 1"raining 
In Patients With Congestive Heart Failure (EXERT) 
R.S McKelvie, K.K. "leo, N McCartney, R.S. Roberts, L,A. Costantini, 
T.J. Montogue, D.P. Humen+ G.H. Guyatt, S. Yusuf. McMaster University 
and University of Alberta, Hamilton and Edmonton, Canada 
Background: Impairment of functional capacity (FC) in heart failure (HF) 
may be due to skeletal muscle abnormalities as well as cardiac dysfunc- 
tion. Exercise training (ET) may improve the abnormalities with concomitant 
improvements of FC and quality of life (QOL) measures. This study was 
designed to assess the effects of 3 & 12 months of ET on FC and QOL in 
HF. 
Methods: 181 patients randomized to usual care or ET. Patients ET for 3 
months (supervised), and then were given exercise equipment to continue ET 
at home• At 3 and 12 months post randomization (R), patients were assessed 
with 6 saute walk test (MWT). peak exercise VO2, dynamic muscle strength 
test. and QOL measures. Rest radionuclide angiography was parformed at 
3 months post R. 
Results: At 3 months peak VO2 increased by 10% (p = 0.026), strength 
increased by 15% (p = 0,01), with no significant change in QOL, 6 MWT or 
